SOPH
SOPHiA Genetics SA

251
Mkt Cap
$325.67M
Volume
79,353.00
52W High
$5.30
52W Low
$2.58
PE Ratio
-4.30
SOPH Fundamentals
Price
$5.01
Prev Close
$4.80
Open
$4.85
50D MA
$4.63
Beta
0.95
Avg. Volume
71,341.68
EPS (Annual)
-$0.946
P/B
5.37
Rev/Employee
$154,073.29
Loading...
Loading...
News
all
press releases
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 32,434 shares, a drop of...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher - What's Next?
SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 2.8% - Here's What Happened...
MarketBeat·11d ago
News Placeholder
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued...
PR Newswire·26d ago
News Placeholder
321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC
Archon Capital Management LLC bought a new stake in shares of SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) during the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·1mo ago
News Placeholder
Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How
TEM's surging Insights revenues, new contracts and expanded AI capabilities highlight its shift toward scalable data-driven growth.
Zacks·1mo ago
News Placeholder
Rathbones Group PLC Takes Position in SOPHiA GENETICS SA $SOPH
Rathbones Group PLC acquired a new stake in SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·2mo ago
News Placeholder
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to...
PR Newswire·2mo ago
News Placeholder
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT and MSK-ACCESS Assays on DNBSEQ-T1+ Platform at AMP 2025
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT and MSK-ACCESS Assays on DNBSEQ-T1+ Platform at AMP 2025 Complete Genomics and SOPHiA GENETICS Announce Integration of...
PR Newswire·2mo ago
News Placeholder
BTIG Research Boosts SOPHiA GENETICS (NASDAQ:SOPH) Price Target to $7.00
BTIG Research raised their price objective on shares of SOPHiA GENETICS from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Monday...
MarketBeat·2mo ago
News Placeholder
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and...
PR Newswire·2mo ago
<
1
2
...
>

Latest SOPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.